| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |